Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of the Osteoporosis Self-Assessment Tool (OST) and Male Osteoporosis Risk Estimate Score (MORES) in Predicting Osteoporosis in Turkish Men

NCT07518212 is registered in ClinicalTrials.gov with Kayseri City Hospital as lead sponsor.

NCT NCT07518212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07518212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of the Osteoporosis Self-Assessment Tool (OST) and Male Osteoporosis Risk Estimate Score (MORES) in Predicting Osteoporosis in Turkish Men
Lead sponsor
Kayseri City Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
February 4, 2026
Completion date
September 15, 2026
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

male osteoporosis